288 related articles for article (PubMed ID: 24916465)
1. Variant CJD and blood transfusion: are there additional cases?
Davidson LR; Llewelyn CA; Mackenzie JM; Hewitt PE; Will RG
Vox Sang; 2014 Oct; 107(3):220-5. PubMed ID: 24916465
[TBL] [Abstract][Full Text] [Related]
2. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study.
Hewitt PE; Llewelyn CA; Mackenzie J; Will RG
Vox Sang; 2006 Oct; 91(3):221-30. PubMed ID: 16958834
[TBL] [Abstract][Full Text] [Related]
3. Variant Creutzfeldt-Jakob disease in a transfusion recipient: coincidence or cause?
Chohan G; Llewelyn C; Mackenzie J; Cousens S; Kennedy A; Will R; Hewitt P
Transfusion; 2010 May; 50(5):1003-6. PubMed ID: 20230536
[TBL] [Abstract][Full Text] [Related]
4. Creutzfeldt-Jakob disease and blood transfusion: updated results of the UK Transfusion Medicine Epidemiology Review Study.
Urwin PJ; Mackenzie JM; Llewelyn CA; Will RG; Hewitt PE
Vox Sang; 2016 May; 110(4):310-6. PubMed ID: 26709606
[TBL] [Abstract][Full Text] [Related]
5. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.
Llewelyn CA; Hewitt PE; Knight RS; Amar K; Cousens S; Mackenzie J; Will RG
Lancet; 2004 Feb; 363(9407):417-21. PubMed ID: 14962520
[TBL] [Abstract][Full Text] [Related]
6. A retrospective case note review of deceased recipients of vCJD-implicated blood transfusions.
Gillies M; Chohan G; Llewelyn CA; MacKenzie J; Ward HJ; Hewitt PE; Will RG
Vox Sang; 2009 Oct; 97(3):211-8. PubMed ID: 19671123
[TBL] [Abstract][Full Text] [Related]
7. Ten-year follow-up of two cohorts with an increased risk of variant CJD: donors to individuals who later developed variant CJD and other recipients of these at-risk donors.
Checchi M; Hewitt PE; Bennett P; Ward HJ; Will RG; Mackenzie JM; Sinka K
Vox Sang; 2016 Nov; 111(4):325-332. PubMed ID: 27432362
[TBL] [Abstract][Full Text] [Related]
8. Is there evidence of vertical transmission of variant Creutzfeldt-Jakob disease?
Murray K; Peters J; Stellitano L; Winstone AM; Verity C; Will RG
J Neurol Neurosurg Psychiatry; 2011 Jul; 82(7):729-31. PubMed ID: 19401289
[TBL] [Abstract][Full Text] [Related]
9. The risk of variant Creutzfeldt-Jakob disease among UK patients with bleeding disorders, known to have received potentially contaminated plasma products.
Zaman SM; Hill FG; Palmer B; Millar CM; Bone A; Molesworth AM; Connor N; Lee CA; Dolan G; Wilde JT; Gill ON; Makris M
Haemophilia; 2011 Nov; 17(6):931-7. PubMed ID: 21342369
[TBL] [Abstract][Full Text] [Related]
10. Transmission of Variant Creutzfeldt-Jakob Disease Through Blood Transfusion and Plasma-Derived Products: A Narrative Review of Observed and Modeled Risks.
Pozzo di Borgo A; Rochette S; Gaussen A; O'Brien SF; Germain M; Renaud C; Lewin A
Transfus Med Rev; 2023 Jul; 37(3):150747. PubMed ID: 37827587
[TBL] [Abstract][Full Text] [Related]
11. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report.
Wroe SJ; Pal S; Siddique D; Hyare H; Macfarlane R; Joiner S; Linehan JM; Brandner S; Wadsworth JD; Hewitt P; Collinge J
Lancet; 2006 Dec; 368(9552):2061-7. PubMed ID: 17161728
[TBL] [Abstract][Full Text] [Related]
12. Insights into the management of emerging infections: regulating variant Creutzfeldt-Jakob disease transfusion risk in the UK and the US.
Ponte ML
PLoS Med; 2006 Oct; 3(10):e342. PubMed ID: 17076547
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a test for its suitability in the diagnosis of variant Creutzfeldt-Jakob disease.
Cooper JK; Andrews N; Ladhani K; Bujaki E; Minor PD
Vox Sang; 2013 Oct; 105(3):196-204. PubMed ID: 23772892
[TBL] [Abstract][Full Text] [Related]
14. Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study.
Dorsey K; Zou S; Schonberger LB; Sullivan M; Kessler D; Notari E; Fang CT; Dodd RY
Transfusion; 2009 May; 49(5):977-84. PubMed ID: 19170987
[TBL] [Abstract][Full Text] [Related]
15. Absence of evidence of transfusion transmission risk of Creutzfeldt-Jakob disease in the United States: Results froma 28-year lookback study.
Crowder LA; Dodd RY; Schonberger LB
Transfusion; 2024 Jun; 64(6):980-985. PubMed ID: 38650381
[TBL] [Abstract][Full Text] [Related]
16. Variant Creutzfeldt-Jakob disease and exposure to fractionated plasma products.
Ward HJ; MacKenzie JM; Llewelyn CA; Knight RS; Hewitt PE; Connor N; Molesworth A; Will RG
Vox Sang; 2009 Oct; 97(3):207-10. PubMed ID: 19538514
[TBL] [Abstract][Full Text] [Related]
17. vCJD and blood transfusion in the United Kingdom.
Hewitt P
Transfus Clin Biol; 2006 Nov; 13(5):312-6. PubMed ID: 17188541
[TBL] [Abstract][Full Text] [Related]
18. No evidence of transfusion transmitted sporadic Creutzfeldt-Jakob disease: results from a bi-national cohort study.
Holmqvist J; Wikman A; Pedersen OBV; Nielsen KR; Rostgaard K; Hjalgrim H; Edgren G
Transfusion; 2020 Apr; 60(4):694-697. PubMed ID: 32187687
[TBL] [Abstract][Full Text] [Related]
19. Risk of variant Creutzfeldt-Jakob disease transmission by blood transfusion in Australia.
McManus H; Seed CR; Hoad VC; Kiely P; Kaldor JM; Styles CE; Yang H; Law M; Gosbell IB
Vox Sang; 2022 Aug; 117(8):1016-1026. PubMed ID: 35609012
[TBL] [Abstract][Full Text] [Related]
20. Transfusion transmission of human prion diseases.
Zou S; Fang CT; Schonberger LB
Transfus Med Rev; 2008 Jan; 22(1):58-69. PubMed ID: 18063192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
